Q3 2017 13F Holders as of 9/30/2017
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
835M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
-1.21M
-
Total reported value, excl. options
-
$811M
-
Value change
-
-$47.7M
-
Put/Call ratio
-
3.38
-
Number of buys
-
53
-
Number of sells
-
-58
-
Price
-
$35.68
Significant Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q3 2017
142 filings reported holding RDY - DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share as of Q3 2017.
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 835M outstanding shares and own 2.72% of the company stock.
Largest 10 shareholders include Fisher Asset Management, LLC (5.47M shares), ROYAL BANK OF CANADA (3.61M shares), Commonwealth Bank of Australia (2.11M shares), BlackRock Inc. (1.48M shares), VANGUARD GROUP INC (1.48M shares), AQR CAPITAL MANAGEMENT LLC (893K shares), STATE STREET CORP (655K shares), DIMENSIONAL FUND ADVISORS LP (582K shares), DEUTSCHE BANK AG\ (465K shares), and UBS Group AG (432K shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.